Where does Evonik Degussa GMBH rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Evonik Degussa GMBH ranks #653 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Evonik Degussa GMBH hold?

Evonik Degussa GMBH holds 686 US utility patents granted between 2015 and 2021, spanning 125 technology areas.

What is Evonik Degussa GMBH's Innovation Score?

Evonik Degussa GMBH has an Innovation Score of 56.9 out of 100 (top 6% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Evonik Degussa GMBH focus on?

Evonik Degussa GMBH's top technology area is C07C (Acyclic OR Carbocyclic Compounds) with 193 patents. Grants appear in 125 CPC subclasses total.

Is Evonik Degussa GMBH's patent grant rate increasing or decreasing?

Evonik Degussa GMBH's recent grant velocity is -97% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Evonik Degussa GMBH's patents?

Evonik Degussa GMBH's patents average 15.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Evonik Degussa GMBH patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Evonik Degussa GMBH

USPTO PatentsView assignee record - 686 granted patents across 125 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07C (Acyclic OR Carbocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Evonik ranks #653 of 49,997 tracked US assignees by granted-patent volume, with 686 patents across 125 technology areas.

#653
of 49,997 US assignees by volume: Top 6%
by Innovation Score (56.9/100): 15.6
avg claims per patent: -97%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R653 · Foreign Corporation #653 · 686 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MID 686 grants
TOP-DECILE #653/49,997
PHOTO-FINISH GM Cruise Holdings
CPC-WIDE C07C · 125 areas
INNOV-PAR 56.9/100
CLAIMS-RICH 15.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -97% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: GM Cruise Holdings LLC (±1 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Lite-on (GUANGZHOU) · near

57
Osram · near

57
Evonik Degussa · this assignee

57
Oceaneering… · near

57
THE Calany Holding… · near

57
3D Lighting… · lowest

7

What this shows Evonik's Innovation Score is 56.9/100 (top 6% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

How Evonik's grant cadence moved

Between 2020–2024, Evonik Degussa GMBH received 23 grants versus 663 in 2015–2019 (-97% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2018 at 157 grants and bottomed in 2021 at 1. Lead class C07C accounts for 28.1% of the portfolio across 125 subclasses. Volume neighbours: Rivian IP Holdings, LLC (#649) and Tianma Microelectronics Co., Ltd. (#657).

Rivian IP Holdings

690
Carl Zeiss Meditec

689
Saturn Licensing

689
The Research Foun…

688
Evonik Degussa ◀

686
GM Cruise Holdings

685
The Brigham and W…

685
Yale University

685
Tianma Microelect…

684

What this shows Evonik holds 686 patents at rank #653, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Evonik

By rank, the assignees closest to #653 in granted patent volume.

Leaders in C07C (Acyclic OR Carbocyclic Compounds)

Other assignees with the most granted patents in Evonik's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Evonik, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (57 here).

Oceaneering International, Inc. 57 THE Calany Holding S.À R.L. 57 Osram GmbH 57 Lite-on Electronics (GUANGZHOU) Limited 57

Similar claim depth

Nearest assignees by average claims per patent (15.6 here).

Fisher & Paykel Healthcare Limited 15.6 avg U.S. Department of Energy 15.6 avg Cryovac, LLC 15.6 avg Colopl, Inc. 15.6 avg

Evonik's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

57 Top 6% higher than 94% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Evonik Degussa GMBH patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	118	17.2%
2016	92	13.4%
2017	142	20.7%
2018	157	22.9%
2019	154	22.4%
2020	22	3.2%
2021	1	0.1%

Which technologies does Evonik Degussa GMBH patent most?

C07C - Acyclic OR Carbocyclic Compounds 193

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 191

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 146

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 125

C08L - Compositions OF Macromolecular Compounds 82

C09D - Coating Compositions, e.g. Paints, Varnishes OR LACQUERS; Filling PASTES; Chemical Paint OR INK REMOVERS; INKS; Correcting FLUIDS; WOODSTAINS; Pastes OR Solids FOR Colouring OR PRINTING; USE OF Materials Therefor 80

C08K - Use of inorganic or non-macromolecular organic substances as compounding ingredients 76

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 67

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 65

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 57

C07D - Heterocyclic Compounds 55

C01B - Non-metallic ELEMENTS; Compounds THEREOF; ; Metalloids OR Compounds Thereof NOT Covered BY Subclass C01c 54

Y10T - Technical Subjects Covered BY Former US Classification 48

B01D - Separation 48

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 38

Top 15 of 125 technology areas

Where it ranks

Overall rank by patents

#653

of 49,997 tracked assignees

Innovation Score

56.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Evonik Degussa GMBH's patent record in context - here's where to go next.

Evonik Degussa GMBH's lead technology class is C07C (Acyclic OR Carbocyclic Compounds), 28.1% of its portfolio - see every assignee active in that class. Explore C07C
Ranked #653 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Evonik Degussa GMBH against Rivian IP Holdings, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 56.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.